BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6098021)

  • 1. Detection of varicella-zoster antibody by immune adherence hemagglutination test.
    Kositanont U; Suvatte V; Wasi C; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):342-7. PubMed ID: 6098021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 4 serological tests--complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination--for assay of antibody to varicella-zoster (V-Z) virus.
    Yamada A; Ogino S; Asano Y; Otsuka T; Takahashi M; Baba K; Yabuuchi H
    Biken J; 1979 Jun; 22(2):55-60. PubMed ID: 231433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A live varicella vaccine in a pediatric community.
    Yabuuchi H; Baba K; Tsuda N; Okada S; Nose O; Seino Y; Tomita K; Ha K; Mimaki T; Ogawa M
    Biken J; 1984 Sep; 27(2-3):43-9. PubMed ID: 6100057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to varicella-zoster virus in Thai children and young adults.
    Kositanont U; Wasi C; Oonsombat P; Suvatte V; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):414-20. PubMed ID: 3006266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
    Chiba Y; Miura J; Kumagai T; Nakao T
    Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibody levels as risk factors in the dissemination of herpes zoster.
    Mazur MH; Whitley RJ; Dolin R
    Arch Intern Med; 1979 Dec; 139(12):1341-5. PubMed ID: 229783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of zoster and evaluation of varicella vaccine with a passive haemagglutination assay.
    Kino Y; Minamishima Y
    Vaccine; 1993; 11(11):1151-3. PubMed ID: 8249435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of antibody to varicella zoster virus by immune adherence hemagglutination].
    Nakajima N; Minohara Y; Goshima F; Arimoto Y; Kaku H; Goshima T; Katoh T; Fukazawa T; Asano Y; Yamauchi T
    Kansenshogaku Zasshi; 1993 Aug; 67(8):730-5. PubMed ID: 8409581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation.
    Forghani B; Schmidt NJ; Dennis J
    J Clin Microbiol; 1978 Nov; 8(5):545-52. PubMed ID: 215602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune adherence hemagglutination test applied to the study of herpes simplex and varicella-zoster virus infections.
    Gillani A; Spence L
    J Clin Microbiol; 1978 Feb; 7(2):114-7. PubMed ID: 204662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live attenuated varicella vaccine: the KMcC strain in healthy children.
    Arbeter AM; Starr SE; Weibel RE; Neff BJ; Plotkin SA
    Pediatrics; 1983 Mar; 71(3):307-12. PubMed ID: 6298698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of immune adherence hemagglutination test in the screening of blood donors carrying a high titer antibody to varicella-zoster virus.
    Kawai H; Sakuma T; Sasaki K; Sato M; Watanabe T; Honda M; Ozaki S; Azuma M
    Tohoku J Exp Med; 1986 Feb; 148(2):143-9. PubMed ID: 3008376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.
    Ozaki T; Matsui T; Ichikawa T; Asano Y; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):39-42. PubMed ID: 6100056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A five-year immunological follow-up study of the institutionalized handicapped children vaccinated with live varicella vaccine or infected with natural varicella.
    Ueda K; Tokugawa K; Nakashima F; Takahashi M
    Biken J; 1984 Sep; 27(2-3):119-22. PubMed ID: 6100048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with the live Oka-strain varicella vaccine in children with solid tumours.
    Heath RB; Malpas JS
    Postgrad Med J; 1985; 61 Suppl 4(721):107-11. PubMed ID: 3014467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella vaccination in HIV-1-infected children after immune reconstitution.
    Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
    AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunofluorescence test for sensitive detection of varicella-zoster virus-specific IgG: an alternative to fluorescent antibody to membrane antigen test.
    Sauerbrei A; Färber I; Brandstädt A; Schacke M; Wutzler P
    J Virol Methods; 2004 Jul; 119(1):25-30. PubMed ID: 15109817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in antibody responses in varicella, herpes zoster and after vaccination.
    Kimoto T; Kurimura T
    Arch Virol; 1979; 59(1-2):59-67. PubMed ID: 218537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical observations on varicella-zoster vaccinees treated with immunosuppressants for a malignancy.
    Nunoue T
    Biken J; 1984 Sep; 27(2-3):115-8. PubMed ID: 6100047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect haemagglutination reaction with varicella-zoster virus antigen.
    Trlifajová J; Pokorný J; Ryba M; Strízová V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):26-36. PubMed ID: 4350836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.